Rectal cancer: The sphincter-sparing approach

David M. Ota, Lisa Jacobs, Boris Kuvshinoff

Research output: Contribution to journalArticle

Abstract

There is considerable skepticism regarding sphincter-preserving surgery for rectal cancer, and 40% to 60% APR rates are reported in many prospective studies. Despite radical surgery, 20% positive margin rates are frequently reported. Rectal carcinoma responds to preoperative chemoradiation therapy with a 10% to 15% pathologic complete response rate. Preoperative therapy offers an opportunity to reduce the positive margin rate and to reduce the APR rate. Because there is significant tumor regression with preoperative therapy, distal margins of less 1 cm are acceptable and do not result in suture line recurrence. APR rate of less than 10% is feasible and better chemotherapy with radiation therapy will reduce the APR to less than 5%.

Original languageEnglish (US)
Pages (from-to)983-993
Number of pages11
JournalThe Surgical clinics of North America
Volume82
Issue number5
DOIs
StatePublished - Oct 2002
Externally publishedYes

Fingerprint

Rectal Neoplasms
Sutures
Radiotherapy
Therapeutics
Prospective Studies
Carcinoma
Recurrence
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Rectal cancer : The sphincter-sparing approach. / Ota, David M.; Jacobs, Lisa; Kuvshinoff, Boris.

In: The Surgical clinics of North America, Vol. 82, No. 5, 10.2002, p. 983-993.

Research output: Contribution to journalArticle

Ota, David M. ; Jacobs, Lisa ; Kuvshinoff, Boris. / Rectal cancer : The sphincter-sparing approach. In: The Surgical clinics of North America. 2002 ; Vol. 82, No. 5. pp. 983-993.
@article{c573683d3b454c97a491a6595207616d,
title = "Rectal cancer: The sphincter-sparing approach",
abstract = "There is considerable skepticism regarding sphincter-preserving surgery for rectal cancer, and 40{\%} to 60{\%} APR rates are reported in many prospective studies. Despite radical surgery, 20{\%} positive margin rates are frequently reported. Rectal carcinoma responds to preoperative chemoradiation therapy with a 10{\%} to 15{\%} pathologic complete response rate. Preoperative therapy offers an opportunity to reduce the positive margin rate and to reduce the APR rate. Because there is significant tumor regression with preoperative therapy, distal margins of less 1 cm are acceptable and do not result in suture line recurrence. APR rate of less than 10{\%} is feasible and better chemotherapy with radiation therapy will reduce the APR to less than 5{\%}.",
author = "Ota, {David M.} and Lisa Jacobs and Boris Kuvshinoff",
year = "2002",
month = "10",
doi = "10.1016/S0039-6109(02)00048-8",
language = "English (US)",
volume = "82",
pages = "983--993",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Rectal cancer

T2 - The sphincter-sparing approach

AU - Ota, David M.

AU - Jacobs, Lisa

AU - Kuvshinoff, Boris

PY - 2002/10

Y1 - 2002/10

N2 - There is considerable skepticism regarding sphincter-preserving surgery for rectal cancer, and 40% to 60% APR rates are reported in many prospective studies. Despite radical surgery, 20% positive margin rates are frequently reported. Rectal carcinoma responds to preoperative chemoradiation therapy with a 10% to 15% pathologic complete response rate. Preoperative therapy offers an opportunity to reduce the positive margin rate and to reduce the APR rate. Because there is significant tumor regression with preoperative therapy, distal margins of less 1 cm are acceptable and do not result in suture line recurrence. APR rate of less than 10% is feasible and better chemotherapy with radiation therapy will reduce the APR to less than 5%.

AB - There is considerable skepticism regarding sphincter-preserving surgery for rectal cancer, and 40% to 60% APR rates are reported in many prospective studies. Despite radical surgery, 20% positive margin rates are frequently reported. Rectal carcinoma responds to preoperative chemoradiation therapy with a 10% to 15% pathologic complete response rate. Preoperative therapy offers an opportunity to reduce the positive margin rate and to reduce the APR rate. Because there is significant tumor regression with preoperative therapy, distal margins of less 1 cm are acceptable and do not result in suture line recurrence. APR rate of less than 10% is feasible and better chemotherapy with radiation therapy will reduce the APR to less than 5%.

UR - http://www.scopus.com/inward/record.url?scp=0036817452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036817452&partnerID=8YFLogxK

U2 - 10.1016/S0039-6109(02)00048-8

DO - 10.1016/S0039-6109(02)00048-8

M3 - Article

C2 - 12507204

AN - SCOPUS:0036817452

VL - 82

SP - 983

EP - 993

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 5

ER -